Supplementary Tables S4 and S5 from Overcoming Clinical Resistance to EZH2 Inhibition Using Rational Epigenetic Combination Therapy

Supplementary Table S4: List of mutations found in all MRT and ES cell lines used in this study as determined by targeted MSK-IMPACT sequencing. Related to Figure 3A.
Supplementary Table S5: List of PDX models used in this study, with clinical characteristics of the original tumor specimens, followed by a list of mutations found in all PDX models, as determined by targeted MSK-IMPACT sequencing.